Shingles mRNA vaccine trial for adults 40 and older
Part of Infections clinical trials.
This study tests a new shingles vaccine (called an mRNA vaccine) given as a shot. It aims to prevent shingles in adults aged 40 and above. If you qualify, you may receive the vaccine or a placebo, and your health will be monitored for a period of time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You must be generally healthy, or have stable chronic conditions.
- You must not have had shingles before, and no chickenpox in the past year.
- You must not have received a shingles or chickenpox vaccine before.
- If you are female and could become pregnant, you must agree to use effective birth control for 6 months after the last dose.
- You must not have a weakened immune system, or a history of heart inflammation or other serious uncontrolled conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
This study tests an investigational vaccine (SYS6017) to see how well it works and if it's safe for adults 40 and older. The vaccine aims to prevent shingles, a painful rash caused by the same virus as chickenpox.
This trial tests a new investigational shingles vaccine to see if it is safe and produces an immune response in healthy adults 40 and older. Participating could help protect against shingles and its complications.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This trial tests a new shingles vaccine in adults 40 and older to see if it is safe and works well. The vaccine is designed to prevent shingles and its complications, which are common in this age group.
Hear when a new Varicella-zoster Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.